Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rory Peters
Observed names:
Peters, Rory,
Rory J.R. Peters,
Rory JR Peters,
Rory James Redmond Peters
Institutions:
Milton Keynes Hospital,
University of Oxford,
Oxford University Hospitals NHS Trust
Observed institutions:
University College London Hospitals NHS Foundation Trust,
The Francis Crick Institute,
Milton Keynes Hospital,
John Radcliffe Hospital,
University of Oxford,
Medawar Building for Pathogen Research,
Oxford University Hospitals NHS Trust,
University College London
show all 8
ORCID:
0000-0003-4347-9739
Observed ORCID:
0000-0003-4347-9739
OpenAlex ID:
A5048692281
Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis
2019
·
Tamsin Cargill
, Mateusz Makuch
, et al.
·
Clinical and Translational Gastroenterology
·
52
An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity
2023
·
Peter A. C. Wing
, Nathalie M. Schmidt
, et al.
·
PLoS Pathogens
·
24
PDF
Disparities in care and outcomes for primary liver cancer in England during 2008–2018: a cohort study of 8.52 million primary care population using the QResearch database
2023
·
Weiqi Liao
, Carol A.C. Coupland
, et al.
·
EClinicalMedicine
·
23
PDF
A novel serum metabolomic panel distinguishes I g G4 ‐related sclerosing cholangitis from primary sclerosing cholangitis
2022
·
Daniel E. Radford‐Smith
, Emmanuel A. Selvaraj
, et al.
·
Liver International
·
13
PDF
Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related disease
2020
·
George Goodchild
, Rory JR Peters
, et al.
·
Clinical Medicine
·
13
PDF
Correspondence on ‘The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease'
2020
·
Rory James Redmond Peters
, Harry Martin
, et al.
·
Annals of the Rheumatic Diseases
·
8
PDF
Correction: Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis
2019
·
Tamsin Cargill
, Mateusz Makuch
, et al.
·
Clinical and Translational Gastroenterology
·
4
P060 Rituximab as third line therapy in IgG4-Related Disease: experience from a multi-centre cohort
2021
·
Charis D Manganis
, Chen X Lee
, et al.
·
Gut
·
1
PDF
P2 A regional evaluation of outcomes at three months for patients admitted to hospital with decompensated alcohol related cirrhosis
2024
·
Christopher Oldroyd
, Sally Pan
, et al.
·
Gut
P40 1H NMR Spectroscopy can distinguish steatotic liver disease and HCC in steatotic liver disease in a prospective patient cohort
2024
·
Rory Peters
, Daniel Radford-Smith
, et al.
·
Gut
Lymphoma in IgG4-related disease: should we be concerned?
2022
·
Arif Hussenbux
, Rory Peters
, et al.
·
Journal of Hepatology
O04 Serum nuclear magnetic resonance metabolomic signature can discriminate immunoglobulin G4-related sclerosing cholangitis and primary sclerosing cholangitis
2021
·
Emmanuel Selvaraj
, Daniel Radford-Smith
, et al.
·
Gut
PDF
P257 Real world experience of the new ACR-EULAR classification criteria for IgG4-related disease
2021
·
Rory Peters
, Harry Martin
, et al.
·
Gut
PDF
A multi-disciplinary approach to igG4 related disease aids in diagnosis and management
2020
·
Rory Peters
, George Goodchild
, et al.
·
Journal of Hepatology
PTU-100 The role of a multi-regional specialist multi-disciplinary meeting in diagnosis and management of igg4-related disease
2019
·
George Goodchild
, Rory Peters
, et al.
·
Gut
PDF
Show more works
View as search
Works count:
16
Citation count:
138
H-index:
6
I10-index:
5
Year
Topic
Type